Trademark: 79308218
Word
IDSIQ
Status
Registered
Status Code
700
Status Date
Tuesday, May 24, 2022
Serial Number
79308218
Registration Number
6726798
Registration Date
Tuesday, May 24, 2022
Mark Type
4000
Filing Date
Wednesday, December 30, 2020
Published for Opposition
Tuesday, March 1, 2022

Trademark Owner History
Idorsia Pharmaceuticals Ltd - Original Registrant

Classifications
41 Multimedia publication of printed matter in the nature of newsletters, brochures, and test results in the nature of test results documents and test result forms in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; multimedia publication of printed matter in the nature of books, magazines and journals in the field of tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
9 Downloadable electronic publications in the nature of newsletters and test results in the nature of test results documents and test result forms the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
16 Printed matter in the nature of newsletters and brochures in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
42 Scientific research and development, namely pharmaceutical testing and medical testing services not for diagnostic or treatment purposes and development of pharmaceutical and medical tests, all which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; scientific research, namely analysis of objective data on patients that was acquired by means of diagnostic tests in the context of drug administration, analysis of subjective data on patients that was acquired by means of patient questioning, analysis of such data with the aim of optimizing drug treatments and drug administration

Trademark Events
Oct 2, 2022
Final Decision Transaction Processed By Ib
Sep 9, 2022
Final Disposition Notice Sent To Ib
Sep 9, 2022
Final Disposition Processed
Aug 24, 2022
Final Disposition Notice Created, To Be Sent To Ib
May 24, 2022
Notice Of Registration Confirmation Emailed
May 24, 2022
Registered-Principal Register
Mar 1, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 1, 2022
Published For Opposition
Feb 28, 2022
Notification Processed By Ib
Feb 9, 2022
Notification Of Possible Opposition Sent To Ib
Feb 9, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 9, 2022
Notification Of Notice Of Publication E-Mailed
Jan 24, 2022
Approved For Pub - Principal Register
Jan 24, 2022
Examiner's Amendment Entered
Jan 24, 2022
Notification Of Examiners Amendment E-Mailed
Jan 24, 2022
Examiners Amendment E-Mailed
Jan 24, 2022
Examiners Amendment -Written
Jan 5, 2022
Teas/Email Correspondence Entered
Jan 5, 2022
Correspondence Received In Law Office
Jan 5, 2022
Teas Response To Office Action Received
Jan 5, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 5, 2022
Teas Change Of Correspondence Received
Jan 5, 2022
Teas Change Of Domestic Representatives Address
Jan 5, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 5, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 5, 2022
Teas Change Of Owner Address Received
Aug 15, 2021
Refusal Processed By Ib
Jul 26, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jul 26, 2021
Refusal Processed By Mpu
Jul 15, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jul 14, 2021
Non-Final Action Written
Jul 3, 2021
Assigned To Examiner
Apr 13, 2021
Application Filing Receipt Mailed
Apr 9, 2021
New Application Office Supplied Data Entered In Tram
Apr 8, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24